Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $85

Colgate-Palmolive Company +0.60%

Colgate-Palmolive Company

CL

85.83

+0.60%

Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE: CL) with a Overweight and lowers the price target from $89 to $85.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via